His main research concerns Internal medicine, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis and Surgery. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Endocrinology. His Inflammatory bowel disease research includes themes of Epidemiology, Incidence, Intensive care medicine, Pediatrics and Cohort.
Crohn's disease is a subfield of Disease that Peter L. Lakatos studies. His work investigates the relationship between Ulcerative colitis and topics such as Cohort study that intersect with problems in Natural history. His studies in Surgery integrate themes in fields like Placebo, Infliximab and Osteoporosis.
Peter L. Lakatos focuses on Internal medicine, Inflammatory bowel disease, Crohn's disease, Ulcerative colitis and Gastroenterology. Peter L. Lakatos interconnects Endocrinology and Surgery in the investigation of issues within Internal medicine. His studies in Inflammatory bowel disease integrate themes in fields like Incidence and Intensive care medicine.
While the research belongs to areas of Crohn's disease, he spends his time largely on the problem of Immunology, intersecting his research to questions surrounding Genotype. The concepts of his Ulcerative colitis study are interwoven with issues in Colitis, Prospective cohort study and Epidemiology. His work carried out in the field of Gastroenterology brings together such families of science as Colorectal cancer and Primary sclerosing cholangitis.
The scientist’s investigation covers issues in Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Crohn's disease and Disease. His Internal medicine study frequently involves adjacent topics like Gastroenterology. His Inflammatory bowel disease research is multidisciplinary, incorporating perspectives in Clostridium difficile, Therapeutic drug monitoring, Epidemiology, Intensive care medicine and Meta-analysis.
His Ulcerative colitis research incorporates themes from Interquartile range, Dysplasia, Colonoscopy, Prospective cohort study and Endoscopy. His Crohn's disease study combines topics in areas such as Biomarker, Quality of life, Calprotectin and Referral. His Disease study combines topics from a wide range of disciplines, such as Hepatology and Population study.
His scientific interests lie mostly in Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Disease and Crohn's disease. Internal medicine is often connected to Gastroenterology in his work. His work in Inflammatory bowel disease covers topics such as Epidemiology which are related to areas like Lower risk.
His Ulcerative colitis research integrates issues from Biological drugs, Receiver operating characteristic, Colitis and Hazard ratio. His biological study spans a wide range of topics, including Combination therapy, Population study, Family medicine and Intensive care medicine. His Crohn's disease research includes themes of Quality of life, Surgery, Disease severity and C-reactive protein.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black;Pierre D. Delmas;Richard Eastell;Ian R. Reid.
The New England Journal of Medicine (2007)
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.
L. Peyrin-Biroulet;W. Sandborn;B. E. Sands;W. Reinisch;W. Reinisch.
The American Journal of Gastroenterology (2015)
The burden of inflammatory bowel disease in Europe.
Johan Burisch;Tine Jess;Matteo Martinato;Peter L. Lakatos.
Journal of Crohn's and Colitis (2013)
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond.
Angelo Agostoni;Emel Aygören-Pürsün;Karen E. Binkley;Alvaro Blanch.
The Journal of Allergy and Clinical Immunology (2004)
The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT)
Dennis M Black;Ian R Reid;Steven Boonen;Christina Bucci-Rechtweg.
Journal of Bone and Mineral Research (2012)
Recent trends in the epidemiology of inflammatory bowel diseases: up or down?
Peter Laszlo Lakatos.
World Journal of Gastroenterology (2006)
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
E. F. Stange;S. P. L. Travis;S. Vermeire;W. Reinisch.
Journal of Crohn's and Colitis (2008)
Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2-year results from the MOBILE study
J-Y Reginster;Silvano Adami;Peter Lakatos;Maria Greenwald.
Annals of the Rheumatic Diseases (2006)
Geographical variability and environmental risk factors in inflammatory bowel disease
Siew C. Ng;Charles N. Bernstein;Morten H. Vatn;Peter Laszlo Lakatos.
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.
Paolo Gionchetti;Axel Dignass;Silvio Danese;Fernando José Magro Dias.
Journal of Crohns & Colitis (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: